Girao Tiago
- SEC CIK
- 0001618670
In the past year, 3 open-market sale filings worth $1.41M and no purchases.
Current role at each company
- IMVT Immunovant, Inc.Chief Financial Officeras of Jul 24, 2026
- LABP Landos Biopharma, Inc.Directoras of May 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.41M
- 3 filings
- Net
- −$1.41M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Girao Tiago as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMVT Immunovant, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 (view filing) | Apr 23 | 1 day | Girao TiagoChief Financial Officer | SSale | −25.8K | $29.62 | −$763.0K | −9.4%247.6K after | |
| Jun 26, 2026 (view filing) | Jun 26 | Same day | Girao TiagoChief Financial Officer | SSale | −10.0K | $38.46 | −$384.6K | −3.9%247.6K after | |
| Jul 24, 2026 (view filing)5:57 PM ET | Jul 23 | 1 day | Girao TiagoChief Financial Officer | SSale | −6.80K | $38.69 | −$263.0K | −2.7%240.8K after |